Precision Medicine: Delivering the right treatment to the right patient at the right time through early diagnosis and individually tailored treatments.
The goal of the Center for Applied Genetics and Genomic Medicine (TCAG2M) is to apply genetics and genomic biology to improve healthcare delivery for the people of Arizona. TCAG2M supports outstanding translational and clinical research into the etiology of disease, and the development of new approaches to manage these conditions in the clinic. To achieve this goal, TCAG2M has created divisions in cancer genetics, cardiopulmonary genetics, genetic consultation and counseling, community engagement, genome technologies and innovation, pharmacogenomics, and population genetics to advance our translational and clinical agenda.
The Center is headquartered at University of Arizona Health Sciences and is tightly connected to the health science colleges in Tucson and Phoenix, as well as various colleges and core facilities throughout the University. TCAG2M facilitates precision health at the University of Arizona through several key ways:
Sponsoring regular seminars to inform researchers, students, clinicians and the public about recent advances in precision health.
Working with industry leaders to advance precision health research at the University of Arizona.
Identification of Biomarker May Lead to Earlier Detection of Stomach Cancer
UArizona researchers recently discovered a promising new biomarker that appears in patients before stomach cancer develops.
A Genetic Approach to Treating Glioblastoma
Precision health—using an individual’s genetic profile to guide decisions regarding prevention, diagnosis and treatment of disease, including diseases stemming from cancer.
Electronics That Vanish in the Body
UA physician and biomaterial expert Dr. Marvin J. Slepian is part of a team that has developed biodegradable electronics that could revolutionize medicine, environmental monitoring and consumer electronics.